Abstract
In this work, the effect of fullerenol on erythropoiesis was investigated in healthy rats and in rats that had suffered blood loss in the amount of 2% of body weight. Fullerenol C60(OH)24 was diluted in 2 mL of 0.9% sodium chloride solution and injected intraperitoneally in a dose of 0.1 or 0.2 mg/kg body weight. The counts of reticulocytes, erythrocytes, and serum erythropoietin levels were determined in 48 and 96 h, as were the numbers of erythroid cells and erythroblastic islands (EIs) of different maturity fractions in the bone marrow and the fraction of the red pulp in the spleen. In intact rats, the reconstruction of erythropoiesis was augmented 1.5-fold in response to 0.1 mg/kg fullerenol C60(OH)24 and 3.3-fold in response to 0.2 mg/kg fullerenol. Both doses increased the number of oxyphylic erythroblasts in the bone marrow twofold, and 0.2 mg/kg fullerenol increased the red pulp fraction in the spleen by 9%; at the same time, fullerenol did not affect the counts of reticulocytes and erythrocytes, or the serum erythropoietin level in the case of normal erythropoiesis. Following hemorrhage, exposure to a 0.2 mg/kg dose of fullerenol C60(OH)24 increased serum erythropoietin levels, delayed the maturation of erythroid cells in EIs, partially blocked the release of reticulocytes from the bone marrow, and promoted an increase in the relative spleen weight and the red pulp fraction in the spleen.
Similar content being viewed by others
References
M. Medrek, F. Pluciski, and A. P. Mazurek, “Endohedral complexes of fullerene C60 with small convalent molecules (H2O, NH3, H2, 2H2, 3H2, 4H2, O2, O3) in the context of potential drug transporter system,” Acta Polon. Pharm. 70 (4), 659–665 (2013).
N. Venkatesan, J. Yoshimitsu, Y. Ito, N. Shibata, and K. Takada, “Liquid filled nanoparticles as a drug delivery tool for protein therapeutics,” Biomaterials 26 (34), 7154–7163 (2005).
S. Trajković, S. Dobrić, V. Jacević, V. Dragojević-Simić, Z. Milovanović, and A. Dordević, “Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats,” Colloids Surf. B: Biointerfaces. 58 (1), 39–43 (2007).
H. Meng, G. Xing, B. Sun, F. Zhao, H. Lei, W. Li, Y. Song, Z. Chen, H. Yuan, X. Wang, J. Long, C. Chen, X. Liang, N. Zhang, Z. Chai, and Y. Zhao, “Potent angiogenesis inhibition by the particulate form of fullerene derivatives,” ACS Nano 4 (5), 2773–2783 (2010).
J. J. Ryan, H. R. Bateman, A. Stover, G. Gomez, S. K. Norton, W. Zhao, L. B. Schwartz, R. Lenk, and C. L. Kepley, “Fullerene nanomaterials inhibit the allergic response,” J. Immunol. 179 (1), 665–672 (2007).
A. S. Basso, D. Frenkel, F. J. Quintana, F. A. Costa-Pinto, S. Petrovic-Stojkovic, L. Puckett, A. Monsonego, A. Bar-Shir, Y. Engel, M. Gozin, and H. L. Weiner, “Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis,” J. Clin. Invest. 118 (4), 1532–1543 (2008).
V. M. Torres, B. Srdjenovic, V. Jacevic, V. D. Simic, A. Djordjevic, and A. L. Simplício, “Fullerenol C60(OH)24 prevents doxorubicin-induced acute cardiotoxicity in rats,” Pharmacol. Rep. 62 (4), 707–718 (2010).
A. Nemmar, P. H. Hoet, B. Vanquickenborne, D. Dinsdale, M. Thomeer, M. F. Hoylaerts, H. Vanbilloen, L. Mortelmans, and B. Nemery, “Passage of inhaled particles into the blood circulation in humans,” Circulation 105 (4), 411–414 (2002).
Y. Zhang, Y. Bai, J. Jia, N. Gao, Y. Li, R. Zhang, G. Jiang, and B. Yan, “Perturbation of physiological systems by nanoparticles,” Chem. Soc. Rev. 43 (10), 3762–3809 (2014).
M. Ghosh, A. Chakraborty, and A. Mukherjee, “Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO2) nanoparticles on human erythrocyte and lymphocyte cells in vitro,” J. Appl. Toxicol. 33 (10), 1097–1110 (2013).
A. Nemmar, S. Beegam, P. Yuvaraju, J. Yasin, A. Shahin, and B. H. Ali, “Interaction of amorphous silica nanoparticles with erythrocytes in vitro: role of oxidative stress,” Cell Physiol. Biochem. 34 (2), 255–265 (2014).
S. Sachar and R. K. Saxena, “Cytotoxic effect of polydispersed single walled carbon nanotubes on erythrocytes in vitro and in vivo,” PLoS One 6 (7), 22032 (2011).
E. A. Kosenko, I. N. Solomadin, and Y. G. Kaminsky, “Effect of the ß-amyloid peptide Aß25-35 and fullerene C60 on the activity of enzymes in erythrocytes,” Russ. J. Bioorg. Chem. 35 (2), 157–162 (2009).
V. A. Shipelin, E. N. Trushina, L. I. Avren’eva, S. Kh. Soto, S. Yu. Batishcheva, G. Yu. Mal’tsev, I. V. Gmoshinskii, S. A. Khotimchenko, and V. A. Tutel’yan, “Toxicological and sanitary characteristics of fullerenol (hydroxylated fullerene C60) in 28-day in vivo experiment,” Nanotechnol. Russ. 8, 799 (2013).
T. Liu, R. Xing, Y. F. Zhou, J. Zhang, Y. Y. Su, K. Q. Zhang, Y. He, Y. H. Sima, and S. Q. Xu, “Hematopoiesis toxicity induced by CdTe quantum dots determined in an invertebrate model organism,” Biomaterials 35 (9), 2942–2951 (2014).
Y. Jin, S. Chen, J. Duan, G. Jia, and J. Zhang, “Europium-doped Gd2O3 nanotubes cause the necrosis of primary mouse bone marrow stromal cells through lysosome and mitochondrion damage,” J. Inorg. Biochem. 146, 28–36 (2015).
Y. Wang, Z. Chen, T. Ba, J. Pu, Y. Gu, J. Guo, and G. Jia, “Genotoxic effects of oral-exposed TiO2 nanoparticles on bone marrow cells in young rats,” Zhonghua Yu Fang Yi Xue Za Zhi 48 (9), 815–818 (2014).
I. Kopova, L. Bacakova, V. Lavrentiev, and J. Vacik, “Growth and potential damage of human bone-derived cells on fresh and aged fullerene C60 films,” Int. J. Mol. Sci 14 (5), 9182–9204 (2013).
N. V. Tishevskaya, Yu. M. Zakharov, E. V. Golubotovskii, O. L. Kolesnikov, N. V. Trofimova, Yu. V. Arkhipenko, and T. G. Sazontova, “Effects of fullerenol C60(OH)24 on erythropoiesis in vitro,” Bull. Exp. Biol. Med. 157, 49 (2014).
Yu. M. Zakharov, I. Yu. Mel’nikov, and A. G. Rassokhin, “Classification of Erythroblastic Islets of Marrow Taking Into Consideration with modification of their cellular structure,” Arkh. Anat., Gistol. Embriol., No. 5, 38–42 (1990).
S. Bancos, D. L. Stevens, and K. M. Tyner, “Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro,” Int. J. Nanomed., No. 10, 183–206 (2014).
J. Y. Lee, W. Park, and D. K. Yi, “Immunostimulatory effects of gold nanorod and silica-coated gold nanorod on RAW 264.7 mouse macrophages,” Toxicol. Lett. 209 (1), 51–57 (2012).
C. F. Borgognoni, M. Mormann, Y. Qu, M. Schäfer, K. Langer, C. Öztürk, S. Wagner, C. Chen, Y. Zhao, H. Fuchs, and K. Riehemann, “Reaction of human macrophages on protein corona covered TiO2 nanoparticles,” Nanomedicine 11 (2), 275–282 (2015).
R. Tordjman and S. Delaire, “Erythroblasts are a source of angiogenic factors,” Blood 97 (7), 1968–1974 (2001).
H. Yamawaki and N. Ivai, “Cytotoxity of water soluble fullerene in vascular endothelial cells,” Am. J. Physiol. Cell 290 (6), 1495–1502 (2006).
J. T. Kwon, D. S. Kim, A. Minai-Tehrani, S. K. Hwang, S. H. Chang, E. S. Lee, C. X. Xu, H. T. Lim, J. E. Kim, B. I. Yoon, G. H. An, K. H. Lee, J. K. Lee, and M. H. Cho, “Inhaled fluorescent magnetic nanoparticles induced extramedullary hematopoiesis in the spleen of mice,” J. Occup. Health 51 (5), 423–431 (2009).
G. Qu, C. Zhang, L. Yuan, J. He, Z. Wang, L. Wang, S. Liu, and G. Jiang, “Quantum dots impair macrophagic morphology and the ability of phagocytosis by inhibiting the Rho-associated kinase signaling,” Nanoscale 4 (7), 2239–2244 (2012).
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © N.V. Tishevskaya, E.V. Golubotovsky, K.O. Pharizova, D.M. Omarova, 2015, published in Rossiiskie Nanotekhnologii, 2015, Vol. 10, Nos. 7–8.
Rights and permissions
About this article
Cite this article
Tishevskaya, N.V., Golubotovsky, E.V., Pharizova, K.O. et al. Effects of fullerenol C60(OH)24 on physiological and compensatory erythropoiesis. Nanotechnol Russia 10, 645–650 (2015). https://doi.org/10.1134/S1995078015040199
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1995078015040199